VIETRI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.799
EU - Europa 2.326
AS - Asia 1.328
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 96
OC - Oceania 8
Totale 6.964
Nazione #
US - Stati Uniti d'America 2.720
IT - Italia 684
RU - Federazione Russa 493
SG - Singapore 416
GB - Regno Unito 320
CN - Cina 318
IE - Irlanda 247
BR - Brasile 212
VN - Vietnam 148
HK - Hong Kong 137
DE - Germania 127
SE - Svezia 120
FR - Francia 99
IN - India 64
FI - Finlandia 55
ZA - Sudafrica 55
BD - Bangladesh 44
UA - Ucraina 44
CA - Canada 39
KR - Corea 38
IQ - Iraq 30
ES - Italia 28
ID - Indonesia 26
NL - Olanda 25
JP - Giappone 24
MX - Messico 18
CZ - Repubblica Ceca 16
PL - Polonia 16
EG - Egitto 15
SA - Arabia Saudita 14
TR - Turchia 14
PK - Pakistan 13
BE - Belgio 11
AR - Argentina 8
AU - Australia 8
EC - Ecuador 8
IR - Iran 8
AT - Austria 7
CI - Costa d'Avorio 7
HR - Croazia 7
BG - Bulgaria 6
KE - Kenya 6
PY - Paraguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
CM - Camerun 4
HN - Honduras 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
JM - Giamaica 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BS - Bahamas 2
DZ - Algeria 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 6.804
Città #
Dallas 411
Southend 254
Ashburn 251
Singapore 244
Dublin 243
San Jose 197
Moscow 160
Santa Clara 155
Fairfield 148
Milan 140
Chandler 131
Hong Kong 123
Beijing 110
Council Bluffs 75
New York 69
Seattle 59
Siena 57
Wilmington 56
Houston 55
Woodbridge 55
Lastra a Signa 54
Johannesburg 50
Los Angeles 46
Rome 45
Helsinki 42
Cambridge 41
Ho Chi Minh City 41
Hefei 37
Munich 35
Princeton 34
Jacksonville 31
Lauterbourg 30
Hanoi 28
Columbus 24
Figino 23
Ann Arbor 22
Buffalo 22
Seoul 22
São Paulo 22
The Dalles 21
Florence 20
Chicago 19
Gavirate 18
Redondo Beach 18
Shanghai 18
San Mateo 17
Tokyo 17
Fremont 16
Haiphong 16
Málaga 16
Nuremberg 16
Orem 16
Dearborn 15
Boardman 14
Phoenix 14
Warsaw 13
Baghdad 12
Brno 12
Boston 11
Denver 11
Frankfurt am Main 11
Hanover 11
Jeddah 11
Montreal 11
Brescia 10
Brooklyn 10
Comun Nuovo 10
London 10
Toronto 10
Chennai 9
Da Nang 9
Jakarta 9
Miami 9
San Diego 9
Atlanta 8
Bengaluru 8
Manchester 8
Mexico City 8
Mumbai 8
Paris 8
Stockholm 8
Abidjan 7
Cagliari 7
Padova 7
Piscataway 7
Portsmouth 7
Rio de Janeiro 7
Anagni 6
Belo Horizonte 6
Brussels 6
Dhaka 6
Lappeenranta 6
Philadelphia 6
San Francisco 6
Turin 6
Turku 6
Washington 6
Agliana 5
Bologna 5
Brasília 5
Totale 4.284
Nome #
Serum amyloid A: a new biomarker in Idiopathic Pulmonary Fibrosis 519
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 454
An explainable model of host genetic interactions linked to COVID-19 severity 400
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 299
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 294
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 281
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 269
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 259
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 259
Serum amyloid A in patients with idiopathic pulmonary fibrosis 252
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 232
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 232
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 222
Serum amyloid A: A potential biomarker of lung disorders 219
Effects of rituximab therapy on B cell differentiation and depletion 210
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 195
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 192
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 183
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 171
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 168
Serum Amyloid A in lung transplantation 152
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital. 146
Author reply 130
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 114
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis 86
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica. 84
Eterogeneità clinica e radiologica della sarcoidosi: case report di sarcoidosi sistemica con coinvolgimento osseo con aspetti di malignità. 71
Role of EBUS-TBNA in interstitial lung diseases: a case report of lymphangitis carcinomatosa. 69
SAA and lipid metabolism in IPF 68
A case report on expanding horizon of endobronchial ultrasound through esophagus 67
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 64
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 58
Biomarkers of Response to Nintedanib in IPF 57
The thin line between sarcoidosis and cancer: can we consider PET as an oncologic screening tool in radiologically stable and asymptomatic sarcoidosis? 57
Atipical radiological NSIP pattern in GLILD: a case report 54
FINDING BAL EOSINOPHILIA IN DESQUAMATIVE INTERSTITIAL PNEUMONIA 53
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 52
A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report. 49
Sarcoidosis and Autoimmune Inflammatory Syndrome Induced by Adjuvants: a case report. 45
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 44
Chilotorace maligno: patogenesi e valore prognostico. 42
MYASTHENIA GRAVIS IN INTERSTITIAL LUNG DISEASE DUE TO RHEUMATOID ARTHRITIS: A RARE COMORBIDITY TO CONSIDER. 39
TH-2 INFLAMMATION: A COMMON PATHWAY BETWEEN UIP PATTERN PULMONARY FIBROSIS AND HYPEREOSINOPHILIC SYNDROME 30
Serum Amyloid A and Lipid Metabolism in Idiopathic Pulmonary Fibrosis: A New Target for Antifibrotic Therapy? 23
Totale 6.964
Categoria #
all - tutte 21.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 0 0 0 26 8 5 14 11 12 47 33 62
2022/2023466 25 52 35 40 27 79 31 57 53 30 30 7
2023/2024589 21 22 63 10 17 142 152 28 4 14 18 98
2024/20251.116 99 50 115 55 132 45 42 50 89 58 123 258
2025/20262.984 219 369 294 361 569 112 282 126 120 205 116 211
2026/2027591 141 145 209 96 0 0 0 0 0 0 0 0
Totale 6.964